These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1355438)

  • 1. Weak anticonvulsant activity of CGP 37849 and CGP 39551 against kindled seizures following systemic administration.
    Cotterell KL; Croucher MJ; Bradford HF
    Eur J Pharmacol; 1992 Apr; 214(2-3):285-7. PubMed ID: 1355438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the competitive NMDA receptor antagonist, CGP 37849, on anticonvulsant activity and adverse effects of valproate in amygdala-kindled rats.
    Löscher W; Hönack D
    Eur J Pharmacol; 1993 Apr; 234(2-3):237-45. PubMed ID: 8097722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholds.
    Croucher MJ; Cotterell KL; Bradford HF
    Neurochem Res; 1992 May; 17(5):409-13. PubMed ID: 1356242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant effects of eliprodil alone or combined with the glycineB receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats.
    Wlaź P; Ebert U; Löscher W
    Neuropharmacology; 1999 Feb; 38(2):243-51. PubMed ID: 10218865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents.
    Schmutz M; Portet C; Jeker A; Klebs K; Vassout A; Allgeier H; Heckendorn R; Fagg GE; Olpe HR; van Riezen H
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):61-6. PubMed ID: 1976233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio.
    Chapman AG; Graham JL; Patel S; Meldrum BS
    Epilepsia; 1991; 32(4):578-87. PubMed ID: 1678345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kindled rats are more sensitive than non-kindled rats to the behavioural effects of combined treatment with MK-801 and valproate.
    Dziki M; Hönack D; Löscher W
    Eur J Pharmacol; 1992 Nov; 222(2-3):273-8. PubMed ID: 1360405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy.
    Löscher W; Rundfeldt C; Hönack D
    Eur J Neurosci; 1993 Nov; 5(11):1545-50. PubMed ID: 7904524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of development of tolerance to anticonvulsant effects of two excitatory amino acid antagonists, CGP [corrected] 37849 and CGP 39551 in genetically epilepsy-prone rats.
    De Sarro G; De Sarro A; Ammendola D; Patel S
    Brain Res; 1996 Sep; 734(1-2):91-7. PubMed ID: 8896813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
    Sato K; Morimoto K; Okamoto M
    Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CGP 37849 and CGP 39551: novel competitive N-methyl-D-aspartate receptor antagonists with potent oral anticonvulsant activity.
    Fagg GE; Olpe HR; Schmutz M; Pozza MF; van Riezen H; Bittiger H; Angst C; Brundish D; Allgeier H; Heckendorn R
    Prog Clin Biol Res; 1990; 361():421-7. PubMed ID: 1981260
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticonvulsant action of a NMDA receptor antagonist CGP 40116 varies only quantitatively during ontogeny in rats.
    Haugvicová R; Mares P
    Fundam Clin Pharmacol; 1998; 12(5):521-5. PubMed ID: 9794150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amygdaloid kindling by repeated focal N-methyl-D-aspartate administration: comparison with electrical kindling.
    Croucher MJ; Cotterell KL; Bradford HF
    Eur J Pharmacol; 1995 Nov; 286(3):265-71. PubMed ID: 8608788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice.
    D'Hooge R; Raes A; Hiramatsu M; Mori A; Van Bogaert PP; De Deyn PP
    Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice.
    Czechowska G; Dziki M; Pietrasiewicz T; Kleinrok Z; Turski WA; Czuczwar SJ
    Eur J Pharmacol; 1993 Feb; 232(1):59-64. PubMed ID: 8096188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant action of both NMDA and non-NMDA receptor antagonists against seizures induced by homocysteine in immature rats.
    Folbergrová J
    Exp Neurol; 1997 Jun; 145(2 Pt 1):442-50. PubMed ID: 9217080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in anticonvulsant potency and adverse effects between dextromethorphan and dextrorphan in amygdala-kindled and non-kindled rats.
    Löscher W; Hönack D
    Eur J Pharmacol; 1993 Jul; 238(2-3):191-200. PubMed ID: 8405092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-methyl-D-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures.
    Holmes KH; Bilkey DK; Laverty R; Goddard GV
    Brain Res; 1990 Jan; 506(2):227-35. PubMed ID: 1967965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.